Institute for Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.23M | Sell |
11,683
-8
| -0.1% | -$2.74K | 0.37% | 53 |
|
|
2026
Q1 | $4.11M | Buy |
11,691
+14
| +0.1% | +$4.99K | 0.44% | 44 |
|
|
2025
Q4 | $3.82M | Buy |
11,677
+55
| +0.5% | +$17.4K | 0.41% | 49 |
|
|
2025
Q3 | $3.28M | Sell |
11,622
-138
| -1% | -$40K | 0.34% | 57 |
|
|
2025
Q2 | $3.28M | Sell |
11,760
-395
| -3% | -$112K | 0.37% | 52 |
|
|
2025
Q1 | $3.79M | Sell |
12,155
-142
| -1% | -$41.9K | 0.49% | 41 |
|
|
2024
Q4 | $3.21M | Sell |
12,297
-94
| -0.8% | -$27.9K | 0.4% | 53 |
|
|
2024
Q3 | $3.99M | Sell |
12,391
-129
| -1% | -$42.2K | 0.5% | 37 |
|
|
2024
Q2 | $3.91M | Buy |
12,520
+185
| +1% | +$54.3K | 0.52% | 35 |
|
|
2024
Q1 | $3.51M | Sell |
12,335
-259
| -2% | -$75.8K | 0.45% | 40 |
|
|
2023
Q4 | $3.63M | Sell |
12,594
-131
| -1% | -$35.7K | 0.59% | 36 |
|
|
2023
Q3 | $3.42M | Sell |
12,725
-97
| -0.8% | -$24.2K | 0.62% | 30 |
|
|
2023
Q2 | $2.85M | Sell |
12,822
-378
| -3% | -$87.7K | 0.48% | 43 |
|
|
2023
Q1 | $3.19M | Sell |
13,200
-264
| -2% | -$64.8K | 0.61% | 34 |
|
|
2022
Q4 | $3.54M | Sell |
13,464
-126
| -0.9% | -$33.8K | 0.74% | 22 |
|
|
2022
Q3 | $3.06M | Sell |
13,590
-36
| -0.3% | -$8.73K | 0.69% | 26 |
|
|
2022
Q2 | $3.31M | Sell |
13,626
-21
| -0.2% | -$5.15K | 0.65% | 27 |
|
|
2022
Q1 | $3.3M | Sell |
13,647
-77
| -0.6% | -$17.7K | 0.53% | 37 |
|
|
2021
Q4 | $3.09M | Buy |
13,724
+188
| +1% | +$39.7K | 0.5% | 40 |
|
|
2021
Q3 | $2.88M | Buy |
13,536
+376
| +3% | +$86.5K | 0.51% | 41 |
|
|
2021
Q2 | $3.21M | Sell |
13,160
-345
| -3% | -$84.9K | 0.56% | 33 |
|
|
2021
Q1 | $3.36M | Sell |
13,505
-389
| -3% | -$92.8K | 0.64% | 31 |
|
|
2020
Q4 | $3.19M | Sell |
13,894
-312
| -2% | -$71.9K | 0.64% | 30 |
|
|
2020
Q3 | $3.61M | Sell |
14,206
-1,390
| -9% | -$344K | 0.82% | 22 |
|
|
2020
Q2 | $3.68M | Sell |
15,596
-495
| -3% | -$113K | 0.9% | 17 |
|
|
2020
Q1 | $3.26M | Sell |
16,091
-746
| -4% | -$163K | 1.01% | 15 |
|
|
2019
Q4 | $4.06M | Buy |
16,837
+229
| +1% | +$50.5K | 0.92% | 15 |
|
|
2019
Q3 | $3.21M | Sell |
16,608
-1,196
| -7% | -$230K | 0.81% | 20 |
|
|
2019
Q2 | $3.28M | Buy |
17,804
+1,422
| +9% | +$255K | 0.73% | 20 |
|
|
2019
Q1 | $3.11M | Sell |
16,382
-1,721
| -10% | -$329K | 0.68% | 24 |
|
|
2018
Q4 | $3.52M | Buy |
18,103
+4,592
| +34% | +$896K | 1.44% | 8 |
|
|
2018
Q3 | $2.8M | Sell |
13,511
-1,653
| -11% | -$326K | 0.94% | 22 |
|
|
2018
Q2 | $2.79M | Buy |
15,164
+821
| +6% | +$145K | 0.89% | 23 |
|
|
2018
Q1 | $2.47M | Buy |
14,343
+3,134
| +28% | +$575K | 0.73% | 26 |
|
|
2017
Q4 | $1.94M | Sell |
11,209
-963
| -8% | -$170K | 0.45% | 57 |
|
|
2017
Q3 | $2.28M | Buy |
12,172
+963
| +9% | +$171K | 0.74% | 32 |
|
|
2017
Q2 | $1.93M | Buy |
+11,209
| New | +$1.82M | 0.53% | 38 |
|
|
2014
Q1 | – | Sell |
-8
| Closed | -$1K | – | 71 |
|
|
2013
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 72 |
|
|
2013
Q3 | $1K | Buy |
+8
| New | +$867 | ﹤0.01% | 67 |
|
Other funds holding AMGN
FFM
SP
Institute for Wealth Management's AMGN Position: Q2 2026 in Review
Institute for Wealth Management reduced its Amgen (AMGN) stake by 0.07% in Q2 2026, selling an estimated $2.74K and leaving 11,683 shares worth $4.23M. The position accounts for 0.37% of the portfolio, ranked #53.
Institute for Wealth Management first reported a position in AMGN in Q3 2013 and has held it in 39 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Institute for Wealth Management held 11,683 shares of Amgen worth $4.23M as of Q2 2026.
- Institute for Wealth Management sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
- Amgen made up 0.37% of Institute for Wealth Management's portfolio in Q2 2026, its #53 holding.
- Institute for Wealth Management first reported a position in Amgen in Q3 2013 and has held it in 39 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.